The CRISPR Renaissance: Jennifer Doudna’s Billion-Dollar Blueprint to Resurrect Genetic Medicine from Commercial Stagnation
The clinical trajectory of KJ Muldoon began with a terrifying ambiguity that remains the nightmare of every new parent. Born in August 2024, the infant was gripped by a profound…
